RFLP for Sst I (Sac I) at the human plasminogen activator inhibitor type 1 (PAI-1) gene locus.
作者信息
Kondo I, Berg K
机构信息
Institute of Medical Genetics, University of Oslo, Norway.
出版信息
Nucleic Acids Res. 1989 Mar 25;17(6):2375. doi: 10.1093/nar/17.6.2375.
Abstract
摘要
相似文献
1
RFLP for Sst I (Sac I) at the human plasminogen activator inhibitor type 1 (PAI-1) gene locus.人纤溶酶原激活物抑制剂1型（PAI - 1）基因位点Sst I（Sac I）的限制性片段长度多态性
Nucleic Acids Res. 1989 Mar 25;17(6):2375. doi: 10.1093/nar/17.6.2375.
2
The human gene for plasminogen activator inhibitor 2 (PAI2) exhibits an EcoRI RFLP.人纤溶酶原激活物抑制剂2（PAI2）基因呈现出一种EcoRI限制性片段长度多态性。
Nucleic Acids Res. 1990 May 11;18(9):2837. doi: 10.1093/nar/18.9.2837-a.
3
Plasminogen activator inhibitor type 1 gene is located at region q21.3-q22 of chromosome 7 and genetically linked with cystic fibrosis.1型纤溶酶原激活物抑制剂基因位于7号染色体的q21.3 - q22区域，与囊性纤维化存在基因连锁关系。
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8548-52. doi: 10.1073/pnas.84.23.8548.
4
BcII RFLP of the plasminogen activator inhibitor type 2 gene (PLANH) on chromosome 18q21-q23.位于18号染色体q21 - q23区域的纤溶酶原激活物抑制剂2基因（PLANH）的BcII限制性片段长度多态性
Nucleic Acids Res. 1990 Dec 11;18(23):7196. doi: 10.1093/nar/18.23.7196.
5
A new BglII RFLP at the epidermal growth factor receptor locus (erbB-1) on chromosome 7.位于7号染色体上表皮生长因子受体基因座（erbB - 1）处的一种新的BglII限制性片段长度多态性。
Nucleic Acids Res. 1989 Mar 25;17(6):2369. doi: 10.1093/nar/17.6.2369.
6
Human T-cell receptor CD3-epsilon (CD3E)/TaqI DNA polymorphism.人类T细胞受体CD3-ε（CD3E）/TaqI DNA多态性
Nucleic Acids Res. 1989 Mar 25;17(6):2374. doi: 10.1093/nar/17.6.2374.
7
A PvuII RFLP at the HOX 1.4 homeobox locus (HOX1D).HOX 1.4 同源异型盒基因座（HOX1D）处的PvuII限制性片段长度多态性
Nucleic Acids Res. 1991 Jul 11;19(13):3755. doi: 10.1093/nar/19.13.3755-a.
8
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.从内皮细胞中克隆人纤溶酶原激活物抑制剂的互补DNA
J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761.
9
Genetic variation at the plasminogen activator inhibitor-1 locus is associated with altered levels of plasma plasminogen activator inhibitor-1 activity.纤溶酶原激活物抑制剂-1基因座的遗传变异与血浆纤溶酶原激活物抑制剂-1活性水平的改变有关。
Arterioscler Thromb. 1991 Jan-Feb;11(1):183-90. doi: 10.1161/01.atv.11.1.183.
10
An anonymous single-copy clone, p55-B1, from chromosome 17 identifies a TaqI RFLP [HGM9 no. D17S86].来自17号染色体的一个匿名单拷贝克隆p55 - B1鉴定出一种TaqI限制性片段长度多态性[人类基因定位第九版，编号D17S86]。
Nucleic Acids Res. 1989 Mar 25;17(6):2371. doi: 10.1093/nar/17.6.2371.
本文引用的文献
1
cDNA cloning of human plasminogen activator-inhibitor from endothelial cells.从内皮细胞中克隆人纤溶酶原激活物抑制剂的互补DNA
J Clin Invest. 1986 Dec;78(6):1673-80. doi: 10.1172/JCI112761.
2
Plasminogen activator inhibitor type-1: reactive center and amino-terminal heterogeneity determined by protein and cDNA sequencing.1型纤溶酶原激活物抑制剂：通过蛋白质和cDNA测序确定的反应中心和氨基末端异质性
FEBS Lett. 1986 Dec 15;209(2):213-8. doi: 10.1016/0014-5793(86)81113-9.
Zotero 插件